MB2 Overview
- Founded
-
2014
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
MB2 General Information
Description
Developer of a portfolio of drug candidates to treat diabetes and related metabolic diseases.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Office
- 12406 Horesham Street
- Carmel, IN 46032
- United States
MB2 Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 29-Oct-2015 | 00.00 | Completed | Generating Revenue | ||
| 1. Early Stage VC | 28-Apr-2015 | 00.00 | 00.00 | Completed | Generating Revenue |
MB2 Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| BioCrossroads | Venture Capital | Minority | 000 0000 | 000000 0 |